We are pioneering a new generation of therapies with best-in-class potential to address a broad spectrum of immunological and inflammatory diseases. By combining external innovation with our proprietary Smart Innovation platform, we are advancing differentiated treatments with the potential to deliver improved outcomes for patients.
Our lead candidates are engineered to address a broad range of immunological and inflammatory conditions, with a focus on optimizing safety, efficacy, and patient convenience.